Substance P and the Trigeminovascular System: From Lab to Migraine Clinic

Comprehensive review of substance P role in the trigeminovascular system covers preclinical mechanisms and clinical translation for migraine pathophysiology and treatment.

Alpay, Berkay et al.·Cephalalgia : an international journal of headache·2025·Moderate EvidenceReview
RPEP-09898ReviewModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
N=not applicable
Participants
Review covering preclinical and clinical migraine research involving substance P

What This Study Found

Comprehensive review of substance P role in the trigeminovascular system covers preclinical mechanisms and clinical translation for migraine pathophysiology and treatment.

Key Numbers

Review covers substance P synthesis, NK-1 receptor signaling, and clinical trial history for NK-1 antagonists in migraine.

How They Did This

Methodology in publication.

Why This Research Matters

Relevant to peptide-based therapeutic applications.

The Bigger Picture

Contributes to peptide therapeutic evidence.

What This Study Doesn't Tell Us

Limitations in publication.

Questions This Raises

  • ?Long-term implications?
  • ?Comparison to evidence?
  • ?Next research?

Trust & Context

Key Stat:
Key finding Comprehensive review of substance P role in the trigeminovascular system covers preclinical mechanis
Evidence Grade:
Based on study design.
Study Age:
Published in 2025.
Original Title:
Substance P and the trigeminovascular system: From preclinical mechanisms to human headache induction.
Published In:
Cephalalgia : an international journal of headache, 45(8), 3331024251355944 (2025)
Database ID:
RPEP-09898

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What does this mean?

Comprehensive review of substance P role in the trigeminovascular system covers preclinical mechanisms and clinical translation for migraine pathophysiology and treatment.

How reliable?

Consult publication and provider.

Read More on RethinkPeptides

Cite This Study

RPEP-09898·https://rethinkpeptides.com/research/RPEP-09898

APA

Alpay, Berkay; Christensen, Rune Häckert; Al-Khazali, Haidar M; Ashina, Messoud; Ashina, Håkan. (2025). Substance P and the trigeminovascular system: From preclinical mechanisms to human headache induction.. Cephalalgia : an international journal of headache, 45(8), 3331024251355944. https://doi.org/10.1177/03331024251355944

MLA

Alpay, Berkay, et al. "Substance P and the trigeminovascular system: From preclinical mechanisms to human headache induction.." Cephalalgia : an international journal of headache, 2025. https://doi.org/10.1177/03331024251355944

RethinkPeptides

RethinkPeptides Research Database. "Substance P and the trigeminovascular system: From preclinic..." RPEP-09898. Retrieved from https://rethinkpeptides.com/research/alpay-2025-substance-p-and-the

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.